Introduction
Influenza A viruses have been shown to infect mice, hamsters, guinea-pigs, ferrets, dogs and monkeys (Smith, Andrewes and Laidlaw, 1933; Taylor and Parodi, 1942; Schulman and Kilbourne, 1965; Todd and Cohen, 1968; Berendt, 1974) , and any of these species could be used in the study of human influenza vaccines. The ferret is probably the species which offers most advantages for these studies, since ferrets are easily infected with small quantities of unadapted virus and produce a clinical response to influenza virus infection similar to that in man and which can be quantified (Smith et al., 1933; Haff, Shriver and Stewart, 1966; Potter et al., 1972) ; however, these animals are relatively large and expensive to house, breed only once or twice a year, and there are no inbred lines of ferret which would give more reproducible immune responses. For these reasons ferrets have not been used to a large extent for the study of influenza vaccines, and some of the same limitations apply to dogs and monkeys. The most commonly used animal in the study of influenza vaccines is the mouse; these animals are relatively inexpensive to keep, breed prolifically and can be obtained as inbred lines. On the other hand, influenza virus infection of mice is predominantly a lower respiratory tract infection requiring in many cases the use of mouse-adapted virus; thus, the infection is distinct from that of man. In addition, lozal antibody in mice can be induced by pathotopic potentiation (Fazekas de St Groth and Donnelley, 1950 ) and live influenza virus infection has been reported to give immunity to heterotypic virus (Schulman and Kilbourne, 1965; Werner, 1966) ; since neither of these phenomena have been reported in man, mice may not be a satisfactory model for the study of human vaccines. For the above reasons, a series of experiments has been carried out to determine the value of hamsters in the study of influenza virus vaccines.
Materials and methods

Animals
Syrian hamsters were obtained from a single, randomly-bred colony at the University of Sheffield. The animals were weaned at 4 weeks of age, and used for experimentation at 6-12 weeks of age when the weight was 50-70 g.
Influenza viruses and virus vaccines
Influenza virus A/FM/1/47 (H1NL) and A/England/ 42/72 (H3N2) were kindly supplied by Dr G. C. Schild, National Institute for Medical Research, Mill Hill, London. Virus pools were prepared by the allantoic inoculation of 10-day embryonated eggs. After incubation for 48 hr at 33°C, the allantoic fluids were harvested and stored at -80°C. The identity of the viruses was confirmed by cross-HI tests using monospecific ferret antisera. Atlanta, Georgia, U.S.A. These vaccines were prepared by Merrell-National Laboratories, Swiftwater, Pennsylvania, U.S.A., by formaldehyde treatment of virus purified by zonal centrifugation. Inactivated influenza virus A/England/42/72 vaccine, the purified surface antigen material derived from this virus and the surface antigen absorbed to alhydrogel were obtained from Dr I. Furminger, Evans Biologicals Ltd, Speke, Liverpool; the production of these materials has been described previously (Brady, Furminger and Stones, 1976) .
Experimental design
Before immunization, a 1-2 ml sample of blood was collected from each hamster from the retroorbital sinus. Groups of animals were then inoculated i.m. with an inactivated influenza virus vaccine in a 0 5 ml volume of phosphate buffered saline (PBS), or infected with live virus. For virus infection, the hamsters were lightly anaesthetized with ether, and the virus was given dropwise, intranasally in a 0-2 ml volume. Three weeks later, a second blood sample was taken, and the animals were inoculated intranasally with a challenge infection of live virus in a 0-2 ml volume. Some animals from each group were killed 3 days following the challenge infection when the lungs were removed and ground withcarborundum powder in PBS to give a 40°/. (w/v) suspension. The lung suspensions were centrifuged at 2500 g for 10 min, and the supernatant fluids titrated for infective virus. In one experiment, nasal washings were obtained 3 days after challenge infection and titrated for virus. These washings were obtained by holding the hamster by the skin at the back of the neck sufficiently tightly to induce the animal to gape. One millilitre of PBS containing 2%o (v/v) bovine serum albumin and antibiotics was then introduced dropwise into the nose and collected with a pipette when the fluid had drained into the buccal cavity. All surviving hamsters were bled 3 weeks after the challenge infection.
Virus isolation
Lung suspensions and nasal washings were stored at -80°C before testing. The titres of virus in these specimens were determined by titration using the allantois-on-shell (AOS) method (Fazekas de St Groth, Withell and Lafferty, 1958) . Shell fragments from four eggs were used for each titration, to overcome variations in the sensitivity of eggs to influenza virus infection.
Haemagglutinin-inhibiting (HI)antibody tests
Serum specimens were treated with cholera filtrate (Burroughs Wellcome Ltd) for 18 hr at 37°C, and subsequently heated for 60 min at 56°C. Following this treatment, the specimens were titrated for HI antibody using the microtitre method (Sever, 1962) as described previously (Potter et al., 1973a) .
Neuraminidase-inhibiting (NI) antibody tests
The titre of NI antibody in hamster sera was determined using the standard World Health Organization (WHO) methods, with WHO standard reagents (Aymard-Henry et al., 1973) .
Results
Response of hamsters to influenza virus A/Englandl 42/72 infection
Groups of hamsters were infected intranasally with dilutions of influenza virus A/England/42/72 in a 0-2 ml volume of PBS. The titres of virus recovered 3 days post-infection from lung suspensions and from nasal washings, together with the changes in serum HI antibody titre, are shown in Table 1 . Virus was recovered from lung suspensions and nasal washings taken 3 days after infection with 10'5-104 5 EID50 of A/England/42/72 virus. In addition, all these animals developed serum HI antibody after virus infection. No obvious signs of lung consolidation were seen in influenza virus-infected hamsters, and the quantity of virus isolated from lung suspensions was relatively small compared to that found in nasal washings. No evidence of virus infection was found in hamsters given 10°-5 EID50 of virus. Thus, hamsters were successfully infected with a dose of A/ England/42/72 virus which was similar to that required to infect ferrets (Potter, unpublished result) .
Rectal temperatures were taken twice daily for 3 days following A/England/42/72 virus infection, but no significant increase in temperature was recorded for any individual animal. Nasal washings were Table 6 . Serum HI antibody was produced in all hamsters inoculated with 600 i.u. of subunit material, and in four of six animals inoculated with 60 i.u. of vaccine; two hamsters inoculated with 600 i.u. of vaccine also developed NI antibody. The antibody response to immunization was similar to that obtained for whole virus vaccine (Table 5) ; however, in contrast to the results obtained with whole virus, none of the hamsters inoculated with 600 i.u. or less of surface antigen material showed immunity to challenge infection with homologous A/England/42/ 72 virus, since infective virus was recovered from lung suspensions from all groups of hamsters (Table  6 ). This lack of immunity was observed for hamsters with serum HI antibody titres comparable to that found in hamsters given whole virus vaccine and which were immune to challenge infection. Table 7 . All hamsters inoculated with 600 i.u. of vaccine and two of four animals inoculated with 60 i.u. of vaccine developed demonstrable serum HI antibody; in addition, all hamsters given 600 or 60 i.u. of vaccine and three of four animals given 6-0 i.u. of vaccine developed NI antibody. Thus, the serum HI antibody response to immunization was similar to that found following immunization with whole virus vaccine, but the absorbed vaccine produced a better NI antibody response. Following challenge infection, virus was not recovered from the lungs of hamsters immunized with 600 or 60 i.u. of surface antigen absorbed vaccine, but virus was recovered from hamsters inoculated with 6-0 i.u. of vaccine. These results show that the degree of immunity induced by the absorbed vaccine was comparable to that induced by whole virus vaccine. The enhanced production of NI antibody induced by the surface antigen absorbed vaccine did not increase the immunity of hamsters to challenge infection, since hamsters given 6-0 i.u. of surface antigen absorbed vaccine produced detectable serum NI antibody but not HI antibody, and these animals were susceptible to challenge virus infection (Table 7) .
Discussion
The present results suggest that hamsters may be useful in the study of influenza virus infection and influenza virus vaccines. The use of ferrets for routine purposes is prohibitively expensive, although this species is possibly the best model for influenza in man (Haff et al., 1966; Potter et al., 1972) . Hamsters breed easily and are relatively inexpensive to maintain. These animals are closely related, since all hamsters in this country originate from a single litter, and this would suggest that results obtained in these animals are reproducible. Influenza virus infection of hamsters is primarily an upper respiratory tract infection; high titres of virus can be obtained from nasal washings, and this, together with the size of the animal, allows serial observations to be made on single animals. In a consideration of suitable animal models to study influenza virus vaccine and immunity to influenza, hamsters may offer some advantage; however, further studies are required to determine if the results obtained in this species are indicative of those in man.
The results of the present study show that hamsters were infected with approximately 30 EID50 of influenza virus A/England/42/72; in other studies, hamsters were infected with 100 EID50 of A/Port Chalmers/73 (H3N2) virus. Titrations of these viruses gave similar results in ferrets, and this indicated that the animal species are of equal susceptibility to infection with unadapted virus. Unlike ferrets, however, hamsters did not produce a febrile response to infection, and no local antibody was detectable in nasal washings taken after infection with A/England/42/72 virus. Both infection and immunization of hamsters with inactivated vaccines induced immunity to homologous challenge virus infection, but not to challenge with heterotypic influenza virus. In this respect, hamsters differ from mice in which heterotypic immunity has been reported following infection with live influenza viruses (Schulman and Kilbourne, 1965; Werner, 1966) . There are no data on heterotypic immunity to influenza virus infection in man, and therefore which of the animal results, either those of hamsters or mice, is more akin to the human reaction remains to be determined.
The titration of inactivated influenza virus vaccines in hamsters showed very large differences in the immunogenicity of the vaccines; these differences were apparent in both normal hamsters and in hamsters primed by heterotypic influenza virus infection (Jennings et al., 1974) . Thus, serum HI antibody was found in hamsters inoculated with 50-150 i.u. of A/FM/1/47 virus, but not in animals inoculated with 1500 i.u. of A/Japan/305/57 vaccine. These differences may be due to either the vagaries of standardization by international units or differences in the immunogenicity of the various influenza virus vaccines tested.
In a study of an inactivated A/England/42/72 vaccine, 600 chick cell agglutination units (CCA) or 60 CCA of whole virus vaccine gave protection against homologous challenge infection; however, immunization with purified virus haemagglutinin and neuraminidase induced similar levels of serum HI antibody but failed to give immunity. The reason for this is not known; the influenza virus subunit material may have failed to induce serum antibodies to other important antigenic components of the virus which were discarded during purification. This seems unlikely as the subunit vaccine absorbed to alhydrogel induced both serum antibody and immunity comparable to that induced by whole virus vaccine. Alternatively, the purified virus subunit material may have failed to stimulate an important component of the immune reaction, such as cellular immunity, which is required for immunity to challenge virus infection. 
